TransMedics Shares Plunge Following Short Seller Allegations
9 hours ago · TransMedics Group (NASDAQ:TMDX) experienced a sharp decline in its stock price today, falling over 15% following the release of a critical report by Scorpion Capital. The report accuses the ...
Why Transmedics Plunged in December | The Motley Fool
3 days ago · In the same press release, Transmedics also narrowed fourth-quarter revenue guidance to a range of $428 million to $432 million, which is at the lower end of its prior October guidance of $425 ...
Why TransMedics Stock Plummeted Today | The Motley Fool
Dec 3, 2024 · Shares of leading organ transplant platform TransMedics (TMDX-7.78%) were down 14% as of noon ET on Wednesday, according to data provided by S&P Global Market Intelligence.
Buying The Dip: How TransMedics Is Set To Soar In Potential ...
Despite a Q3 revenue miss and temporary issues, TransMedics' long-term growth prospects remain strong, with plans for next-gen OCS technology and fleet expansion. Read more here.
TransMedics Group, Inc. (TMDX) Latest Stock News & Headlines ...
Get the latest TransMedics Group, Inc. (TMDX) stock news and headlines to help you in your trading and investing decisions.
Is TransMedics Group Stock a Buy? | The Motley Fool
Nov 15, 2024 · Shares of TransMedics have been under pressure following a weaker-than-expected earnings report. The company continues to generate strong growth from its market-leading organ transplant system....
In the news - Transmedics
TransMedics Group (NASDAQ:TMDX) is transforming the standard of care in solid organ transplants in order to increase the number of organ transplants and improve clinical outcomes.